This is the first time this intervention has been conducted in Europe, and the second in the world. Thanks to the work of the expert group of Hospital Clínic de Barcelona, the extirpation of a kidney ‒affected by a malignant tumour‒ through the vagina has been achieved. This fact sets a milestone in the framework of minimally invasive surgery. The operation, presented this morning in a press conference, uses several cutting edge technology instruments of advanced surgery.
ANN ARBOR, Mich. — An international blood pressure study comparing two single-pill drug combinations has yielded results so significant that the study has been stopped early and the researchers say their findings might alter the way high blood pressure is treated worldwide.
Lowering the blood pressure of elderly patients could cut their total mortality by a fifth and their rate of cardiovascular events by a third, according to a new study presented today (Monday 31 March) at the American College of Cardiology in Chicago and published simultaneously in the New England Journal of Medicine.
Hamilton, ON (March 31, 2008) A major Canadian-led global study has found that a new blood pressure medication is effective in reducing cardiovascular death, with fewer side effects than the current standard of care.
The study found a new drug telmisartan is as effective as the popular drug ramipril in reducing cardiovascular death in high risk patients and it has fewer side effects.
One of the earliest general anaesthetics to be used by the medical profession, chloroform, has shed light on a mystery thats puzzled doctors for more than 150 years how such anaesthetics actually work.
A discovery described as true serendipity made by Leeds University PhD student Dr Yahya Bahnasi, has provided a clue that may unravel the enigma of general anaesthesia and offer the opportunity to design new generations of anaesthetics without harmful side effects.
CHICAGO, Ill. (March 31, 2008) � Early results of the SPIRIT II study showed that the XIENCE V stent was superior to the Taxus stent in six-month findings on angiography and trended better on one-year clinical outcomes. Now, a new analysis shows that after two years, the investigational everolimus-coated XIENCE V stent may continue to hold a clinical edge over its paclitaxel-coated competitor.
CHICAGO, Ill. (March 31, 2008) — Percutaneous coronary intervention (PCI) may be a reasonable alternative to bypass surgery in patients with blockages in the left main coronary artery, according to a study that found no significant difference in rates of survival when stents and bypass surgery were used to restore blood flow through this critically important artery. Patients who were treated with stenting were more likely to need a repeat procedure to keep the artery open, however.
CHICAGO, Ill. (March 31, 2008) — A large community-based registry of patients treated with drug-eluting stents is providing important insight into how long patients with complex coronary artery disease typically stick to their doctors orders to take clopidogrel, a drug that prevents unwanted blood clots; why they stop taking the drug; and the long-term consequences of that decision.
CHICAGO, Ill. (March 31, 2008) — A new medication that researchers had hoped would reduce the risk of arterial renarrowing after stenting has turned in a disappointing performance in a multicenter clinical trial, but the multi-reservoir stent that was used to deliver the drug is still considered promising.
Sitewide
